Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
13,019,261
-
Share change
-
-1,779,559
-
Total reported value
-
$72,182,000
-
Price per share
-
$5.65
-
Number of holders
-
26
-
Value change
-
-$5,432,925
-
Number of buys
-
17
-
Number of sells
-
11
Institutional Holders of INTEC PHARMA LTD JERUSALEM - SHS as of Q3 2018
As of 30 Sep 2018,
INTEC PHARMA LTD JERUSALEM - SHS was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,019,261 shares.
The largest 10 holders included
MEITAV DASH INVESTMENTS LTD, venBio Select Advisor LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Prosight Management, LP, Sectoral Asset Management Inc, Harel Insurance Investments & Financial Services Ltd., Migdal Insurance & Financial Holdings Ltd., DAFNA Capital Management LLC, Knott David M, and 683 Capital Management, LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.